ANDRX CORP
SC 13G, 1997-02-14
PHARMACEUTICAL PREPARATIONS
Previous: ANDRX CORP, SC 13G, 1997-02-14
Next: PRODUCTIVITY TECHNOLOGIES CORP /, 10-Q, 1997-02-14



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 13G

                    UNDER THE SECURITIES EXCHANGE ACT OF 1934



                                ANDRX CORPORATION
- -------------------------------------------------------------------------------
                                (Name of Issuer)


                          COMMON STOCK, $.001 PAR VALUE
- -------------------------------------------------------------------------------
                         (Title of Class of Securities)


                                    034551101
- -------------------------------------------------------------------------------
                                 (CUSIP Number)




Check the following box if a fee is being paid with this statement |_|. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).

                                Page 1 of 5 Pages
                              There are no exhibits
<PAGE>


                                      CUSIP No. 034551101

(1)     Names of Reporting Persons                Elliot F. Hahn, Ph.D.
                         
        S.S. or I.R.S. Identification Nos. of Above Persons  
                            
(2)     Check the Appropriate Box if a Member of a Group
        (See Instructions (a)  [ |  (b)  [ ]

(3)     SEC Use Only                    

(4)     Citizenship or Place of Organization              U.S.A.             
                               
        Number of            (5)    Sole Voting Power                      0 
        Shares Bene-
        ficially             (6)    Shared Voting Power            1,591,399 
        Owned by
        Each Report-         (7)    Sole Dispositive Power                 0 
        ing Person
        With                 (8)    Shared Dispositive Power       1,591,399 

(9)     Aggregate Amount Beneficially Owned by Each Reporting
        Person           1,591,399  1     
     
(10)    Check if the Aggregate Amount in Row (9) Excludes Certain Shares 
        (See Instructions[ ]

(11)    Percent of Class Represented by Amount in Row (9)        11.9% 2
                  
(12)    Type of Reporting Person (See Instructions)                 IN  

- --------

        1      Includes 738,895 shares of Common Stock held in a trust, 790,004
               shares of Common Stock held in trust for the benefit of Dr.
               Hahn's children and 62,500 shares of Common Stock owned by a
               general partnership of which Dr. Hahn is a general partner.

        2      Calculated on the basis of 13,414,709 shares of Common Stock
               outstanding on December 31, 1996.


                                Page 2 of 5 Pages
                              There are no exhibits
<PAGE>



Item 1(a).     Name of Issuer:

               ANDRX CORPORATION
 
Item 1(b).     Address of Issuer's Principal Executive Officer:

               4001 SW 47th Avenue, Suite 201
               Fort Lauderdale, Florida 33314

Item 2(a).     Name of Person Filing:

               Elliot F. Hahn, Ph.D.

Item 2(b).     Address of Principal Business Office:

               4001 SW 47th Avenue, Suite 201
               Fort Lauderdale, Florida 33314

Item 2(c).     Citizenship:

               U.S.A.

Item 2(d).     Title of Class of Securities:

               Common Stock, $.001 Par Value

Item 2(e).     CUSIP Number:

               034551101

Item 3.        If this statement is filed pursuant to Rules 13d-1(b), or 
               13d-2(b), identify the status of the person filing.

               Not applicable

Item 4.        Ownership:

               (a)    Amount beneficially Owned:        1,591,399 1 shares
- --------

        1      Includes 738,895 shares of Common Stock held in a trust, 790,004
               shares of Common Stock held in trust for the benefit of Dr.
               Hahn's children and 62,500 shares of Common Stock owned by a
               general partnership of which Dr. Hahn is a general partner.

                                Page 3 of 5 Pages
                              There are no exhibits
<PAGE>


<TABLE>
<CAPTION>

        (b)    Percent of Class:       11.8% 2

        (c)    Number of shares as to which such person has:

<S>                                                                                       <C> 
               (I)    sole power to vote or to direct the vote                            0   

               (ii)   shared power to vote or to direct the vote                  1,591,399   

               (iii)  sole power to dispose or to direct the disposition of               0   

               (iv)   shared power to dispose or to direct the disposition of     1,591,399   
</TABLE>

Item 5.        Ownership of Five Percent or Less of a Class.

               If this statement is being filed to report the fact that as of
               the date hereof the reporting person has ceased to be the
               beneficial owner of more than five percent of the class of
               securities, check the following [ ]

Item 6.        Ownership of More than Five Percent on Behalf of Another Person.

               Not applicable

Item 7.        Identification and Classification of the Subsidiary Which 
               Acquired the Security Being Reported on by the Parent Holding
               Company.

               Not applicable

Item 8.        Identification and Classification of Members of the Group.

               Not applicable

Item 9.        Notice of Dissolution of Group.

               Not applicable

Item 10.       Certification.

               Not applicable

- --------
        2      Calculated on the basis of 13,414,709 shares of Common Stock 
               outstanding on December 31, 1996.


                                Page 4 of 5 Pages
                              There are no exhibits
<PAGE>



                                    SIGNATURE

        After reasonable inquiry and to the best of my knowledge and belief, I 
certify that the information set forth in this statement is true, complete and
correct.




                                            /s/ ELLIOT F. HAHN, Ph.D
February 10, 1997                           ----------------------------------
                                            ELLIOT F. HAHN, Ph.D.















                                Page 5 of 5 Pages
                              There are no exhibits


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission